EADV 2019 Archives - Medical Conferences

Home > Dermatology > EADV 2019

European Academy of Dermatology and Venereology 9-13 October 2019, Madrid, Spain

Letter from the Editor

Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Nijmegen

Late-Breaking News

IL-17A blocker effective in paediatric psoriasis patients

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Rituximab beats mycophenolate mofetil in pemphigus vulgaris

Presented By

Prof. Pascal Joly, Rouen University Hospital, France

Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata

Presented By

Dr James Cassella

Acne highly influenced by climate, pollutants, and unhealthy diet

Presented By

Dr Delphine Kerob, Vichy Laboratories, France

JAK inhibition plus TCS lead to high clearance rates in AD

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

No cancer risk with long-term use of tacrolimus, a topical calcineurin inhibitor, in children with AD

Presented By

Prof. Regina Fölster-Holst, University Medical Center Schleswig-Holstein, Germany

Green light for a second JAK inhibitor in AD

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Topical ruxolitinib effective in vitiligo

Presented By

Prof. Amit Pandya, University of Texas Southwestern Medical Center, USA

Emerging Therapies

Small molecules: interesting novel treatment options in AD

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, German

IL-1⍺ blockade: a new treatment option in AD

Presented By

Prof. Alice Gottlieb, Icahn School of Medicine at Mount Sinai, USA

IL-4/IL-13 blockade leads to rapid itch reduction in adolescents

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

How to manage conjunctivitis in AD patients treated with a biologic

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, Germany

Biologics: increasingly used in paediatric dermatology

Presented By

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Spotlight on Psoriasis

IL-17 blocker: effective and safe in patients with comorbidities

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Relationship psoriasis and NAFLD: new data on the hepato-dermal axis

Presented By

Dr Daniel Nieto, La Paz Hospital, Spain

Novel selective IL-23 blocker equally effective in patients with metabolic syndrome

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

Selective IL-23 blocker crushes fumaric acids in all assessed efficacy endpoints

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

No hint of teratogenicity through ixekizumab

Presented By

Prof. Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

New Insights in Photoprotection

Systemic photoprotection: a valuable addition to topical sun protection

Presented By

Prof. Salvador González Rodriguez, University of Alcala de Henares, Spain

The underestimated effect of visible light

Presented By

Dr Serena Lembo, University of Naples Federico II, Italy

Urticaria

Comorbidities more common in chronic urticaria, psoriasis, and AD

Presented By

Dr Karsten Weller, Charité University Hospital, Germany

D-Dimer as future biomarker in CSU management?

Presented By

Dr Antonio Cristaudo, San Gallicano Dermatological Institute, Italy

Ligelizumab for CSU: symptom control and high response rates in re-treatment

Presented By

Prof. Marcus Maurer, Charité – Universitätsmedizin Berlin, Germany

Rosacea – From New Spectrum to New Therapy

The Rosacea Tracker may aid clinical decision-making

New guidance on rosacea therapy according to phenotype

Presented By

Prof. Martin Schaller, University of Tübingen, Germany

Best of the Posters

Above-the-neck melanoma more prone to metastases

Presented By

Dr Mohammed Al Abadie, Cross Hospital; Cannock Chase Hospital, United Kingdom

Reduced sleep quality in dermatoses influenced by itch and pain

Presented By

Dr Karolina Kaaz, Wroclaw Medical University, Poland

Anxiety and depression are common in families of AD infants

Presented By

Dr Vesna Grivcheva-Panovska, University Clinic in Skopje (Macedonia)

Certolizumab pegol efficacious for head and neck psoriasis

Presented By

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Table of Contents

Featured articles

Late-Breaking News

Emerging Therapies

Spotlight on Psoriasis

New Insights in Photoprotection

Urticaria

Rosacea – From New Spectrum to New Therapy

Best of the Posters